P138. Lumbar fusion success in patients with degenerative lumbar disease without spondylolisthesis: A global study comparing anterolateral versus posterior MIS approaches

2021 ◽  
Vol 21 (9) ◽  
pp. S208-S209
Author(s):  
Yung Park ◽  
Yann Philippe Charles ◽  
Carlos Santos ◽  
Yueming Song ◽  
Shisheng He ◽  
...  
2003 ◽  
Vol 38 (7) ◽  
pp. 659 ◽  
Author(s):  
Ki Tack Kim ◽  
Kyung Soo Suk ◽  
Sang Hun Lee ◽  
Jin Moon Kim

2019 ◽  
Vol 31 (1) ◽  
pp. 1-14 ◽  
Author(s):  
Patrick C. Reid ◽  
Simon Morr ◽  
Michael G. Kaiser

Lumbar fusion is an accepted and effective technique for the treatment of lumbar degenerative disease. The practice has evolved continually since Albee and Hibbs independently reported the first cases in 1913, and advancements in both technique and patient selection continue through the present day. Clinical and radiological indications for surgery have been tested in trials, and other diagnostic modalities have developed and been studied. Fusion practices have also advanced; instrumentation, surgical approaches, biologics, and more recently, operative planning, have undergone stark changes at a seemingly increasing pace over the last decade. As the general population ages, treatment of degenerative lumbar disease will become a more prevalent—and costlier—issue for surgeons as well as the healthcare system overall. This review will cover the evolution of indications and techniques for fusion in degenerative lumbar disease, with emphasis on the evidence for current practices.


2018 ◽  
Vol 10 (1) ◽  
Author(s):  
Ahmed Hosny Khalifa ◽  
Timo Stübig ◽  
Oliver Meier ◽  
Christian Walter Müller

Following lumbar fusion, adjacent segment degeneration has been frequently reported. Dynamic systems are believed to reduce main fusion drawbacks. We conducted a retrospective study on patients with degenerative lumbar disease treated with posterior dynamic stabilization with monoaxial hinged pedicular screws and lumbar decompression. VAS and ODI were used to compare clinical outcomes. As radiological outcomes, LL and SVA were used. 51 patients were included with an average follow-up of 24 months. 13 patients were revised because of postoperative radiculopathy (n=4), subcutaneous hematoma(n=2), L5 screw malposition (n=1) and adjacent segment disease (n=6). The mean ODI score 41 preoperatively compared to 36 postoperatively. The mean VAS scores for back and leg pain were 5.3 and 4.2, respectively compared to 4.5 and 4.0 post-operatively. The mean SVA was 5.3 cm pre-operatively, and 5.7 cm postoperatively. The mean LL was 47.5° preoperatively and 45.5° postoperatively. From our data, whichfail to show significant improvements andreflect a high revision rate, we cannot generally recommend dynamic stabilization as an alternative to fusion. Comparative trials with longer follow-ups are required.


2011 ◽  
Vol 16 (2) ◽  
pp. 8-9
Author(s):  
Marjorie Eskay-Auerbach

Abstract The incidence of cervical and lumbar fusion surgery has increased in the past twenty years, and during follow-up some of these patients develop changes at the adjacent segment. Recognizing that adjacent segment degeneration and disease may occur in the future does not alter the rating for a cervical or lumbar fusion at the time the patient's condition is determined to be at maximum medical improvement (MMI). The term adjacent segment degeneration refers to the presence of radiographic findings of degenerative disc disease, including disc space narrowing, instability, and so on at the motion segment above or below a cervical or lumbar fusion. Adjacent segment disease refers to the development of new clinical symptoms that correspond to these changes on imaging. The biomechanics of adjacent segment degeneration have been studied, and, although the exact mechanism is uncertain, genetics may play a role. Findings associated with adjacent segment degeneration include degeneration of the facet joints with hypertrophy and thickening of the ligamentum flavum, disc space collapse, and translation—but the clinical significance of these radiographic degenerative changes remains unclear, particularly in light of the known presence of abnormal findings in asymptomatic patients. Evaluators should not rate an individual in anticipation of the development of changes at the level above a fusion, although such a development is a recognized possibility.


2010 ◽  
Author(s):  
B. Greiner ◽  
E. Rosskam ◽  
V. McCarthy ◽  
M. Mateski ◽  
L. Zsoldos ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document